Sarepta Therapeutics Inc. (SRPT) is Trading Lower on Unusual Volume for January 15

Equities Staff |

Sarepta Therapeutics Inc. (SRPT) experienced unusually high volume on Jan. 15, as the stock lost 54.63% to a closing price of $14.35. The stock saw 16.01 million shares trade hands over the course of the day on 77,401 trades. Given that the stock’s average daily volume over the last month has been 1.1 million shares a day, this represents a pretty substantial spike over the norm.

Sarepta Therapeutics Inc. has a P/B ratio of 5.28. The stock has traded between $41.97 and $11.42 over the last 52-weeks, its 50-day SMA is now $33.77, and its 200-day SMA $29.26.

Sarepta Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases.

Headquartered in Cambridge, MA, Sarepta Therapeutics Inc. has 204 employees and is currently under the leadership of CEO Edward M. Kaye.

For a complete fundamental analysis analysis of Sarepta Therapeutics Inc., check out’s Stock Valuation Analysis report for SRPT. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets


Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…